Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
17.53
-0.04 (-0.23%)
At close: Feb 9, 2026, 4:00 PM EST
17.53
0.00 (0.00%)
After-hours: Feb 9, 2026, 4:49 PM EST
Keros Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$23.00
Upside
+31.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +8.39% | Nov 28, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $23 → $27 | Buy | Reiterates | $23 → $27 | +54.02% | Nov 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $26 → $23 | Buy | Maintains | $26 → $23 | +31.20% | Nov 11, 2025 |
| Wedbush | Wedbush | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -8.73% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +14.09% | Aug 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $32 → $18 | Strong Buy → Hold | Downgrades | $32 → $18 | +2.68% | Jun 10, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | -14.43% | May 30, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $41 → $26 | Buy | Maintains | $41 → $26 | +48.32% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $25 | Strong Buy | Maintains | $40 → $25 | +42.61% | May 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $43 → $25 | Strong Buy | Maintains | $43 → $25 | +42.61% | Apr 9, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | -14.43% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +128.18% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +48.32% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $40 | Strong Buy | Maintains | $47 → $40 | +128.18% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $15 | Buy | Maintains | $40 → $15 | -14.43% | Jan 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.